Championing Cutting Edge Innovation with Robust Patent Protection: Who’s Setting the Agenda on Biologics? - McDermott Will & Emery

Championing Cutting Edge Innovation with Robust Patent Protection: Who’s Setting the Agenda on Biologics?

Overview


Michael Siekman will speak on a patenting biologics panel at LSPN North America 2022 on the topic of “Championing Cutting Edge Innovation with Robust Patent Protection: Who’s setting the agenda on biologics?.”

Click here for more information and to register.

Dig Deeper

San Francisco, CA / McDermott Event / January 10, 2023

McDermott at the 2023 J.P. Morgan Healthcare Conference

Webinar Series / / October 5, November 9, December 8

McDermott IP Focus

Paris, France / McDermott Event / October 18, 2022

European Healthcare & Life Sciences Symposium

Get In Touch